Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTarsus Regulatory News (TRS)

  • There is currently no data for TRS

Interim Management Statement

17 Apr 2008 07:00

Tarsus Group PLC17 April 2008 Tarsus Group plc ("Tarsus or "the Group") Interim Management Statement and Annual General Meeting At today's Annual General Meeting Neville Buch, the Chairman of Tarsus, willpresent the following Interim Management Statement. Tarsus is today publishing its first Interim Management Statement relating tothe period from 1 January 2008 to 16 April 2008. Trading performance The current year has begun well with the Group's trading performance for thisperiod fully up to the Board's expectations. A summary of the more significantdevelopments includes: • In the US: - a 6% increase in revenues at the February Off-Price show comparedwith the February 2007 event. • In France:- overall revenues for the period were slightly ahead of the sameperiod last year. Of particular note was the performance of the Februaryedition of the Mod'Amont clothing show, a joint venture with Premiere Vision,which produced revenues 8% higher year-on-year. • In Emerging Markets: - overall like-for-like revenues for the period more thandoubled. The fourth edition of the Chinese travel event, COTTM, finishedyesterday with revenues 35% ahead of last year and a record attendance. Acquisition There was one transaction in the period. On 3 March 2008 Tarsus announced theacquisition of 50 per cent of the share capital of Hubei Hope ExhibitionCompany Limited ('Hope') for a maximum total consideration of RMB 20 million (approximately £1.4 million). The acquisition is conditional on receiving approval by the Chinese governmentwhich is expected shortly. Hope will provide a platform for further growth inthe more developed Shanghai market and also gives Tarsus a leading position in the fast developing Central and Western Chinese markets. Financial Position There have been no significant changes to the financial position of the Groupsince the publication of the preliminary results on 3 March 2008. The Group'snet debt is currently £30.2 million (£29.0 million as at 31 December 2007), alsoin line with the Board's expectations. The Group's major currency exposure is to the US dollar. In 2008, this exposurewill be slightly higher than in 2007 as a result of Labelexpo being held in theUS. Outlook The phasing of some of the Group's major events favours the odd years and theBoard continues to be confident about the Group's prospects for 2008 withforward bookings ahead of 2007 on a like-for-like basis. The directorsanticipate a continuation of the trend of the past 3 years with double-digitlike-for-like organic revenue growth. The Group's largest event of the year- Labelexpo Americas in September - now hasover 99% of expected space revenues contracted. The French division, which isheavily second half weighted, is continuing to benefit from the sales reorganisation undertaken in 2007 and strong cost management in 2008. Forwardbookings remain solid, led by continuing strong performances from IPConvergence and Mod'Amont. The Group's medical division continues to exceed expectations. The Orlando showlater this month is on track to produce organic revenue growth of at least 30%driven by the expanded educational aspect of the event. Bookings for the August Las Vegas Off-Price exhibition are tracking ahead of the corresponding 2007event. Neville Buch, Chairman of Tarsus, commented: "We believe that the Group will continue to benefit from the migration of mediaspend towards exhibitions and the internet as well as the increasing demandfrom our customers to sell and market their products in faster growth emergingmarkets. Tarsus derives its strength from its market-leading products, an increasinglydiversified portfolio, both by sector and geography, and an experiencedmanagement team. The year has begun well and we remain confident of furtherstrong progress over the 2008/2009 cycle."For further information please contact: Tarsus Group plc: Douglas Emslie, Group Managing Director: 020 8846 2700 Media:Matthew Moth, Madano Partnership: 020 7593 4000 Investors/Analysts:Neville Harris, IRfocus: 020 7593 4015Stephen Scott, Annabel Michie, Scott Harris 020 7653 0030 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
24th Sep 20077:02 amRNSAcquisition
5th Sep 20077:00 amRNSInterim Results
5th Sep 20077:00 amRNSAcquisition
24th Jul 20078:18 amRNSCapRegen First Day of Dealing
12th Jul 20077:00 amRNSAcquisition
2nd Jul 20077:00 amRNSTrading Statement
2nd Jul 20077:00 amRNSTrading Statement
29th Jun 20072:29 pmRNSAdditional Listing
26th Jun 20072:24 pmRNSLaunch & Float of CapRegen
24th May 200711:47 amRNSDirector/PDMR Shareholding
18th May 20074:20 pmRNSHolding(s) in Company
11th May 20073:18 pmRNSDirShrHolding & Add Listing
2nd May 20075:33 pmRNSAdditional Listing
30th Apr 20072:32 pmRNSDirector/PDMR Shareholding
20th Apr 20072:53 pmRNSHolding(s) in Company
20th Apr 20072:50 pmRNSTVR & Director Shareholding
18th Apr 20074:59 pmRNSResult of AGM
18th Apr 20077:00 amRNSAGM Statement
30th Mar 20074:05 pmRNSTotal Voting Rights
28th Mar 200712:45 pmRNSHolding(s) in Company
28th Mar 200712:43 pmRNSHolding(s) in Company
22nd Mar 20076:26 pmRNSDocument submissions
20th Mar 20072:08 pmRNSHolding(s) in Company
20th Mar 20071:50 pmRNSHolding(s) in Company
16th Mar 20074:57 pmRNSAdditional Listing
14th Mar 20075:13 pmRNSPDMR Options
9th Mar 20075:26 pmRNSHolding(s) in Company
8th Mar 20074:52 pmRNSPDMR Option Excercise
8th Mar 20074:49 pmRNSAnnual Information Update
7th Mar 200711:57 amRNSHolding(s) in Company
1st Mar 20077:03 amRNSFinal Results
14th Feb 20077:00 amRNSChinese Partnership
26th Jan 20075:15 pmRNSHolding(s) in Company
23rd Jan 20077:00 amRNSNotice of Results
4th Jan 20077:01 amRNSDirectorate Change
4th Jan 20077:00 amRNSTrading Statement
18th Dec 200610:21 amRNSAdditional Listing
15th Dec 20065:33 pmRNSTotal Voting Rights
23rd Nov 200611:02 amRNSHolding(s) in Company
16th Nov 20067:02 amRNSAcquisition & Vendor Placing
2nd Nov 200611:29 amRNSChinese Business Presentation
1st Nov 20067:00 amRNSAdditional Listing
3rd Oct 20067:00 amRNSAcquisition
26th Sep 20064:14 pmRNSScrip Dividend Circular
19th Sep 200610:51 amRNSDirector/PDMR Shareholding
4th Sep 20067:02 amRNSInterim Results
31st Aug 20067:00 amRNSNotice of Results
4th Jul 20065:29 pmRNSDirector/PDMR Shareholding
4th Jul 20067:00 amRNSTrading Statement
24th Apr 20062:09 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.